Correction to: Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis

Read full text
Cited by: 0

Fields of Study & Subjects

Inflammatory Bowel Disease Psoriasis: Treatment and Pathogenesis Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
Journal of Crohn s and Colitis
Volume
20
Issue
2
Publication date
8 January 2026
Language
EN